GetFugu Financial Statements From 2010 to 2025
| GFGU Etf | USD 0.0001 0.00 0.00% |
Check GetFugu financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GetFugu's main balance sheet or income statement drivers, such as , as well as many indicators such as . GetFugu financial statements analysis is a perfect complement when working with GetFugu Valuation or Volatility modules.
GetFugu |
GetFugu Company Price To Sales Analysis
GetFugu's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current GetFugu Price To Sales | 64.65 X |
Most of GetFugu's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GetFugu is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, GetFugu has a Price To Sales of 64 times. This is 133.06% higher than that of the Industrials family and significantly higher than that of the Specialty Business Services category. The price to sales for all United States etfs is notably lower than that of the firm.
GetFugu Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GetFugu's current stock value. Our valuation model uses many indicators to compare GetFugu value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GetFugu competition to find correlations between indicators driving GetFugu's intrinsic value. More Info.GetFugu is one of the top ETFs in price to sales as compared to similar ETFs. It also is one of the top ETFs in beta as compared to similar ETFs . Comparative valuation analysis is a catch-all technique that is used if you cannot value GetFugu by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About GetFugu Financial Statements
GetFugu shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although GetFugu investors may analyze each financial statement separately, they are all interrelated. The changes in GetFugu's assets and liabilities, for example, are also reflected in the revenues and expenses on on GetFugu's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
GetFugu, Inc. develops mobile search tools and mobile e-commerce platform. GetFugu, Inc. was founded in 2007 and is based in West Hollywood, California. Getfugu operates under Specialty Business Services classification in the United States and is traded on OTC Exchange. It employs 33 people.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in GetFugu Pink Sheet
GetFugu financial ratios help investors to determine whether GetFugu Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GetFugu with respect to the benefits of owning GetFugu security.